Literature DB >> 25400095

The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases.

Erica Gianazza1, Elena Tremoli, Cristina Banfi.   

Abstract

Selected reaction monitoring, also known as multiple reaction monitoring, is a powerful targeted mass spectrometry approach for a confident quantitation of proteins/peptides in complex biological samples. In recent years, its optimization and application have become pivotal and of great interest in clinical research to derive useful outcomes for patient care. Thus, selected reaction monitoring/multiple reaction monitoring is now used as a highly sensitive and selective method for the evaluation of protein abundances and biomarker verification with potential applications in medical screening. This review describes technical aspects for the development of a robust multiplex assay and discussing its recent applications in cardiovascular proteomics: verification of promising disease candidates to select only the highest quality peptides/proteins for a preclinical validation, as well as quantitation of protein isoforms and post-translational modifications.

Entities:  

Keywords:  biomarkers; cardiovascular diseases; endogenous proteins; mass spectrometry; multiple reaction monitoring; post-translational modifications; protein isoforms; selected reaction monitoring; targeted proteomics

Mesh:

Substances:

Year:  2014        PMID: 25400095     DOI: 10.1586/14789450.2014.947966

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  8 in total

1.  Lysozyme aptasensor based on a glassy carbon electrode modified with a nanocomposite consisting of multi-walled carbon nanotubes, poly(diallyl dimethyl ammonium chloride) and carbon quantum dots.

Authors:  Behzad Rezaei; Hamid Reza Jamei; Ali Asghar Ensafi
Journal:  Mikrochim Acta       Date:  2018-02-14       Impact factor: 5.833

2.  Attenuation of Equine Lentivirus Alters Mitochondrial Protein Expression Profile from Inflammation to Apoptosis.

Authors:  Cheng Du; Yingyi Duan; Xue-Feng Wang; Yuezhi Lin; Lei Na; Xinhui Wang; Kewei Chen; Xiaojun Wang
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 3.  Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.

Authors:  Nathan P Manes; Aleksandra Nita-Lazar
Journal:  J Proteomics       Date:  2018-02-13       Impact factor: 4.044

4.  Lipid-Based Nutrient Supplements During Pregnancy and Lactation Did Not Affect Human Milk Oligosaccharides and Bioactive Proteins in a Randomized Trial.

Authors:  Josh M Jorgensen; Charles Arnold; Per Ashorn; Ulla Ashorn; David Chaima; Yin Bun Cheung; Jasmine Cc Davis; Yue-Mei Fan; Elisha Goonatilleke; Emma Kortekangas; Chiza Kumwenda; Carlito B Lebrilla; Kenneth Maleta; Sarah M Totten; Lauren D Wu; Kathryn G Dewey
Journal:  J Nutr       Date:  2017-10-01       Impact factor: 4.798

Review 5.  Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics.

Authors:  Erica Gianazza; Maura Brioschi; Roberta Baetta; Alice Mallia; Cristina Banfi; Elena Tremoli
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

6.  Multiplexed MRM-Based Proteomics Identified Multiple Biomarkers of Disease Severity in Human Heart Failure.

Authors:  Maura Brioschi; Erica Gianazza; Piergiuseppe Agostoni; Beatrice Zoanni; Alice Mallia; Cristina Banfi
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

Review 7.  Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review.

Authors:  Li Zhong; Lin Zhu; Zong-Wei Cai
Journal:  J Anal Test       Date:  2021-09-08

8.  Identification and Quantitation of Bioactive and Taste-Related Dipeptides in Low-Salt Dry-Cured Ham.

Authors:  Alejandro Heres; Marta Gallego; Leticia Mora; Fidel Toldrá
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.